Return to search

Amedica Sets IPO Terms

Amedica Corp., a Salt Lake City-based maker of orthopedic implants, has set its IPO terms to 4.65 million common shares being offered at between $13 and $15 per share. It would be valued at approximately $230 million, if it were to price at the top of its proposed range. Amedica plans to trade on the Nasdaq under ticker symbol AMCA, with Morgan Stanley serving as lead underwriter. The company has raised over $44 million in total funding since November 2003, including a $13.2 million Series D round earlier this month. Shareholders include Vestal Venture Capital and Creation Capital.